Dialysis Devices Global Market - Forecast to 2022

Publishing Date : June, 2016
Report Code : HCMD0136
Price:
Single license $4,500
Site license $6,300
Global license $9,000


Note: The report would be dispatched after confirmation of payment

The dialysis devices global market is expected to grow at a mid range single digit CAGR to reach $19,289 million by 2022. Dialysis is the treatment method for the patients with kidney failure, it replaces the function of kidneys by removing the wastes and excess fluid from the patient’s blood and thus the treatment helps to keep the patient body’s electrolytes such as sodium, potassium and chloride in balance.

Increasing number of ESRD patients & substantial healthcare expenditure on the treatment of end-stage renal disease (ESRD), growing number of patients suffering from diabetes and hypertension, rise in aging population, rising adoption of dialysis procedures over renal transplants, technological advancements and new product launches are driving the market growth.

Risk and complications associated with dialysis, product recalls, limited reimbursements for dialysis in developing countries, reimbursement cuts for dialysis in North America and stringent regulatory policies for the approval of new dialysis devices.

The dialysis devices global market by type is mainly segmented into hemodialysis and peritoneal dialysis. Hemodialysis market further segmented by products into machines and consumables, and by modalities into conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Hemodialysis machines sub-segmented into center-use hemodialysis machines and home-use hemodialysis machines whereas the hemodialysis consumables sub-segmented into dialyzers, access products, bloodlines, concentrates/dialysate, water treatment systems and other hemodialysis consumables. The dialyzers further segmented as cellulose-based and synthetic dialyzers based on material type, and high-flux and low-flux dialyzers based on flux type. Hemodialysis access products are further segmented as arteriovenous (AV) fistula, A-V Graft and central venous catheter (CVC). Hemodialysis water treatment systems mainly segmented as central water disinfection systems and portable water disinfection systems and these further segmented as chemical disinfection systems, heat disinfection systems and accessories individually. Peritoneal dialysis market segmented into peritoneal dialysis concentrate/dialysate, machines, catheters, transfer sets and others by-products, and continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) by modality.

The dialysis devices market by end-users is mainly segmented into In-Center dialysis and Home dialysis. The In-Centre dialysis further segmented into Hospital dialysis and Dialysis Centers whereas the Home dialysis is further segmented into Peritoneal Dialysis and Home Hemodialysis.

The dialysis devices global market by geography is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Europe region commanded the largest market share.  Increasing incidence of end-stage renal disease (ESRD), increasing hemodialysis facilities, increasing aging populations and increasing awareness of dialysis therapies are driving the European dialysis devices market growth. However, Asia-Pacific region is the fastest growing region due to growing number of ESRD patients, increasing healthcare expenditure, increasing awareness of healthcare, and refining healthcare infrastructure in the emerging countries, such as India and China.

Major players in dialysis devices global market include are Asahi Kasei Corp. (Japan), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), JMS Co. Ltd. (Japan), Kawasumi Laboratories (Japan), Nikkiso Co., Ltd. (Japan), Nipro Corporation (Japan), NxStage Medical Inc. (U.S.) and Toray Industries Inc. (Japan).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET OVERVIEW
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING THE MARKET
    • 3.4     MARKET DYNAMICS
      • 3.4.1     DRIVERS
        • 3.4.1.1     GROWING NUMBER OF PATIENTS SUFFERING FROM DIABETES AND HYPERTENSION
        • 3.4.1.2     RISE IN AGING POPULATION
        • 3.4.1.3     INCREASING NUMBER OF ESRD PATIENTS AND SUBSTANTIAL HEALTHCARE COST ON THE TREATMENT OF END-STAGE RENAL DISEASE
        • 3.4.1.4     RISING ADOPTION OF DIALYSIS PROCEDURES OVER RENAL TRANSPLANTS
        • 3.4.1.5     TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES.
      • 3.4.2     RESTRAINTS
        • 3.4.2.1     RISKS AND COMPLICATIONS ASSOCIATED WITH DIALYSIS
        • 3.4.2.2     PRODUCT RECALLS
        • 3.4.2.3     LIMITED REIMBURSEMENTS FOR DIALYSIS IN DEVELOPING COUNTRIES
        • 3.4.2.4     REIMBURSEMENT CUTS FOR DIALYSIS IN NORTH AMERICA
        • 3.4.2.5     STRINGENT REGULATORY POLICIES FOR THE APPROVAL OF NEW DIALYSIS PRODUCTS
      • 3.4.3     OPPORTUNTIES
        • 3.4.3.1     EMERGING MARKETS OFFER LUCRATIVE GROWTH OPPORTUNITIES
        • 3.4.3.2     EVOLUTION OF USER - FRIENDLY AND LOW COST DIALYSIS PRODUCTS.
        • 3.4.3.3     INCREASING NUMBER OF DIALYSIS CENTERS
        • 3.4.3.4     GROWING ADOPTION OF HOME HEMODIALYSIS TREATMENT
      • 3.4.4     CHALLENGES
        • 3.4.4.1     BENEFITS OF RENAL TRANSPLANTATION VERSUS DIALYSIS
        • 3.4.4.2     SUSTAINABILITY OF PLAYERS IN THE MARKET
    • 3.5     REGULATORY AFFAIRS
      • 3.5.1     U.S.
      • 3.5.2     EUROPE
      • 3.5.3     CHINA
      • 3.5.4     INDIA
      • 3.5.5     JAPAN
    • 3.6     PORTER'S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     BARGAINING POWER OF SUPPLIERS
      • 3.6.4     BARGAINING POWER OF BUYERS
      • 3.6.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.7     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
    • 3.8     PATENT TRENDS
    • 3.9     REIMBURSEMENT SCENARIO
    • 3.10   CPT CODES
    • 3.11     TECHNOLOGICAL ADVANCEMENTS
      • 3.11.1     DIALYSIS MACHINES
      • 3.11.2     DIALYZERS
      • 3.11.3     WATER TREATMENT SYSTEMS
      • 3.11.4     WEARABLE ARTIFICIAL KIDNEY
      • 3.11.5     IMPLANTABLE ARTIFICIAL KIDNEY
    • 3.12     UPCOMING TECHNOLOGIES
    • 3.13     CLINICAL TRIALS
  • 4     DIALYSIS DEVICES GLOBAL MARKET, BY TYPE
    • 4.1     INTRODUCTION
    • 4.2     HEMODIALYSIS MARKET
      • 4.2.1     HEMODIALYSIS MARKET, BY PRODUCTS
        • 4.2.1.1     HEMODIALYSIS MACHINES
          • 4.2.1.1.1     CENTRE-USE HEMODIALYSIS MACHINES
          • 4.2.1.1.2     HOME-USE HEMODIALYSIS MACHINES
        • 4.2.1.2     HEMODIALYSIS CONSUMABLES
          • 4.2.1.2.1     DIALYZERS
            • 4.2.1.2.1.1     DIALYZERS MARKET, BY MATERIAL TYPE
              • 4.2.1.2.1.1.1     CELLULOSE BASED DIALYZERS
              • 4.2.1.2.1.1.2     SYNTHETIC DIALYZERS
            • 4.2.1.2.1.2     DIALYZERS MARKET, BY FLUX TYPE
              • 4.2.1.2.1.2.1      HIGH-FLUX DIALYZERS
              • 4.2.1.2.1.2.2     LOW-FLUX DIALYZERS
          • 4.2.1.2.2     HEMODIALYSIS ACCESS PRODUCTS
            • 4.2.1.2.2.1     ARTERIOVENOUS (AV) FISTULA
            • 4.2.1.2.2.2     A-V GRAFT
            • 4.2.1.2.2.3     CENTRAL VENOUS CATHETER (CVC)
          • 4.2.1.2.3     BLOODLINES
          • 4.2.1.2.4      HEMODIALYSIS CONCENTRATES/DIALYSATE
          • 4.2.1.2.5     OTHER HEMODIALYSIS CONSUMABLES
            • 4.2.1.2.5.1      WATER TREATMENT SYSTEMS
              • 4.2.1.2.5.1.1     CENTRAL WATER DISINFECTION SYSTEMS
                • 4.2.1.2.5.1.1.1     CHEMICAL DISINFECTION SYSTEMS
                • 4.2.1.2.5.1.1.2     HEAT DISINFECTION SYSTEMS
                • 4.2.1.2.5.1.1.3     ACCESSORIES
              • 4.2.1.2.5.1.2     PORTABLE WATER DISINFECTION SYSTEMS
                • 4.2.1.2.5.1.2.1     CHEMICAL DISINFECTION SYSTEMS
                • 4.2.1.2.5.1.2.2     HEAT DISINFECTION SYSTEMS
                • 4.2.1.2.5.1.2.3     ACCESSORIES
      • 4.2.2     HEMODIALYSIS MARKET, BY MODALITY
        • 4.2.2.1     CONVENTIONAL LONG-TERM HEMODIALYSIS
        • 4.2.2.2     SHORT DAILY HEMODIALYSIS
        • 4.2.2.3     NOCTURNAL HEMODIALYSIS
    • 4.3     PERITONEAL DIALYSIS
      • 4.3.1     PERITONEAL DIALYSIS, BY PRODUCTS
        • 4.3.1.1     PERITONEAL DIALYSIS MACHINES
        • 4.3.1.2     PERITONEAL DIALYSIS CONSUMABLES
          • 4.3.1.2.1      PERITONEAL DIALYSIS CONCENTRATE/DIALYSATE
          • 4.3.1.2.2     PERITONEAL DIALYSIS CATHETERS
          • 4.3.1.2.3     PERITONEAL DIALYSIS TRANSFER SETS
          • 4.3.1.2.4     OTHER PERITONEAL DIALYSIS PRODUCTS
      • 4.3.2     PERITONEAL DIALYSIS MARKET, BY MODALITY
        • 4.3.2.1     CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
        • 4.3.2.2     AUTOMATED PERITONEAL DIALYSIS (APD)
  • 5     DIALYSIS DEVICES GLOBAL MARKET, BY END-USERS
    • 5.1     INTRODUCTION
    • 5.2     IN-CENTRE DIALYSIS
      • 5.2.1     HOSPITAL DIALYSIS
      • 5.2.2     DIALYSIS CENTERS
    • 5.3     HOME DIALYSIS
      • 5.3.1     PERITONEAL DIALYSIS
      • 5.3.2     HOME HEMODIALYSIS
  • 6     DIALYSIS DEVICES GLOBAL MARKET, BY REGION
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
    • 6.3     EUROPE
    • 6.4     ASIA PACIFIC
    • 6.5     REST OF THE WORLD
  • 7     COMPANY DEVELOPMENTS
    • 7.1     INTRODUCTION
    • 7.2     AGREEMENTS & EXPANSIONS
    • 7.3     MERGERS & ACQUISITIONS
    • 7.4     APPROVALS
    • 7.5     NEW PRODUCT LAUNCHES
  • 8     MAJOR COMPANIES
    • 8.1     ASAHI KASEI CORP.
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     B. BRAUN MELSUNGEN AG
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     BAXTER INTERNATIONAL, INC.
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     FRESENIUS SE & CO. KGAA
      • 8.4.1     OVERVIEW
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     JMS CO., LTD.
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     SWOT ANALYSIS
    • 8.6     KAWASUMI LABORATORIES, INC.
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     NIKKISO CO., LTD.
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     NIPRO CORPORATION
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     NXSTAGE MEDICAL, INC.
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.10     TORAY INDUSTRIES, INC.
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS

LIST OF TABLES

  • TABLE 1     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 2     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 3     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 4     HEMODIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 5     HEMODIALYSIS DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 6     HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 7     HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 8     CENTRE-USE HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 9     HOME-USE HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 10     HEMODIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 11     HEMODIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 12     HEMODIALYSIS DIALYZERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 13     HEMODIALYSIS DILAYZERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 14     CELLULOSE BASED DIALYZERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 15     SYNTHETIC DIALYZERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 16     HEMODIALYSIS DIALYZERS GLOBAL MARKET REVENUE, BY FLUX TYPE, (2014-2022) ($MN)
  • TABLE 17     HIGH-FLUX DIALYZERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 18     LOW-FLUX DIALYZERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 19     HEMODIALYSIS ACCESS PRODUCTS GLOBAL MARKET REVENUE, BY SEGMENTS, (2014-2022)($MN)
  • TABLE 20     HEMODIALYSIS ACCESS PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 21     ARTERIOVENOUS (AV) FISTULA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 22     A-V GRAFT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 23     CENTRAL VENOUS CATHETER (CVC) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 24     HEMODIALYSIS BLOODLINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 25     HEMODIALYSIS CONCENTRATES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 26     OTHER HEMODIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 27     HEMODIALYSIS GLOBAL MARKET REVENUE, BY MODALITIES, (2014-2022) ($MN)
  • TABLE 28     CONVENTIONAL LONG-TERM HEMODIALYSIS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 29     SHORT DAILY HEMODIALYSIS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 30     NOCTURNAL HEMODIALYSIS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 31     PERITONEAL DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 32     PERITONEAL DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
  • TABLE 33     PERITONEAL DIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 34     PERITONEAL DIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 35     PERITONEAL DIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 36     PERITONEAL DIALYSIS CONCENTRATES/ DIALYSATES GLOBAL MARKET REVENUE, BY REGION, (2014-2022)($MN)
  • TABLE 37     PERITONEAL DIASLYSIS CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 38     PERITONEAL DIALYSIS TRANSFER SETS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 39     OTHER PERITONEAL DIALYSIS PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 40     PERITONEAL DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY MODALITY, (2014-2022) ($MN)
  • TABLE 41     CONTINOUS AMBULATORY PERITONEAL DIALYSIS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 42     AUTOMATED PERITONEAL DIALYSIS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 43     DIALYSIS END-USERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 44     IN-CENTRE DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 45     IN-CENTRE DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 46     HOSPITAL DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 47     DIALYSIS CENTRES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 48     HOME DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 49     HOME DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 50     PERITONEAL DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 51     HOME HEMODIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 52     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • TABLE 53     NORTH AMERICAN DIALYSIS DEVICES MARKET REVENUE, BY TYPE (2014-2022) ($MN)
  • TABLE 54     NORTH AMERICAN HEMODIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
  • TABLE 55     NORTH AMERICAN HEMODIALYSIS MACHINES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 56     NORTH AMERICAN HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 57     NORTH AMERICAN HEMODIALYSIS DIALYZERS MARKET REVENUE, BY MATERIAL TYPE, (2014-2022) ($MN)
  • TABLE 58     NORTH AMERIAN HEMODIALYSIS DIALYZERS MARKET REVENUE, BY FLUX TYPE, (2014-2022) ($MN)
  • TABLE 59     NORTH AMERICAN HEMODIALYSIS ACCESS PRODUCTS MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 60     NORTH AMERICAN HEMODIALYSIS DEVICES MARKET REVENUE, BY MODALITIES, (2014-2022) ($MN)
  • TABLE 61     NORTH AMERICAN PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
  • TABLE 62     NORTH AMERICAN PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 63     NORTH AMERICAN PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES, (2014-2022) ($MN)
  • TABLE 64     NORTH AMERICAN DIALYSIS DEVICES MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
  • TABLE 65     NORTH AMERICAN IN-CENTRE DIALYSIS DEVICES MARKET REVENUE, BY SEMENTS, (2014-2022) ($MN) 232
  • TABLE 66     NORTH AMERICAN HOME DIALYSIS MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 67     EUROPEAN DIALYSIS DEVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 68     EUROPEAN HEMODIALYSIS DEVICES MARKET REVENUE, BY PROUCTS, (2014-2022) ($MN)
  • TABLE 69     EUROPEAN HEMODIALYSIS MACHINES MARKET REVENUE, BY TYPES (2014-2022) ($MN)
  • TABLE 70     EUROPEAN HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 71     EUROPEAN HEMODIALYSIS DIALYZESR MARKET REVENUE, BY MATERIAL TYPE (2014-2022) ($MN)
  • TABLE 72     EUROPEAN HEMODIALYSIS DIALYZERS MARKET REVENUE, BY FLUX TYPE (2014-2022) ($MN)
  • TABLE 73     EUROPEAN HEMODIALYSIS ACCESS PRODUCTS MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 74     EUROPEAN HEMODIALYSIS DEVICES MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
  • TABLE 75     EUROPEAN PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
  • TABLE 76     EUROPEAN PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 77     EUROPEAN PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
  • TABLE 78     EUROPEAN DIALYSIS DEVICES MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
  • TABLE 79     EUROPEAN IN-CENTRE DIALYSIS DEVICES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 80     EUROPEAN HOME DIALYSIS MARKET REVENUE, BY SEGMENTS
  • TABLE 81     ASIA-PACIFIC DIALYSIS DEVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
  • TABLE 82     ASIA-PACIFIC HEMODIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
  • TABLE 83     ASIA-PACIFIC HEMODIALYSIS MACHINES MARKET REVENUE, BY TYPE (2014-2022) ($MN)
  • TABLE 84     ASIA-PACIFIC HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMNETS (2014-2022) ($MN)
  • TABLE 85     ASIA-PACIFIC HEMODIALYSIS DIALYZERS MARKET REVENUE, BY MATERIAL TYPE (2014-2022) ($MN)
  • TABLE 86     ASIA-PACIFIC HEMODIALYSIS DIALYZERS MARKET REVENUE, BY FLUX TYPE (2014-2022) ($MN)
  • TABLE 87     ASIA-PACIFIC HEMODIALYSIS ACCESS PRODUCTS MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 88     ASIA-PACIFIC HEMODIALYSIS DEVICES MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
  • TABLE 89     ASIA-PACIFIC PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
  • TABLE 90     ASIA-PACIFIC PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 91     ASIA-PACIFIC PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
  • TABLE 92     ASIA-PACIFIC DIALYSIS DEVICES MARKET REVENUE, BY END-USERS (2014-2022) ($MN)
  • TABLE 93     ASIA-PACIFIC IN-CENTRE DIALYSIS MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 94     ASIA-PACIFIC HOME DIALYSIS MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
  • TABLE 95     REST OF THE WORLD DIALYSIS MARKET REVENUE, BY TYPES, (2014-2022) ($MN)
  • TABLE 96     REST OF THE WORLD HEMODIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
  • TABLE 97     REST OF THE WORLD HEMODIALYSIS MACHINES MARKET REVENUE, BY TYPE (2014-2022) ($MN)
  • TABLE 98     REST OF THE WORLD HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 99     REST OF THE WORLD HEMODIALYSIS DIALYZERS MARKET REVENUE, BY MATERIAL TYPE (2014-2022) ($MN)
  • TABLE 100     REST OF THE WORLD HEMODIALYSIS DIALYZERS MARKET REVENUE, BY FLUX TYPE (2014-2022) ($MN)
  • TABLE 101     REST OF THE WORLD HEMODIALYSIS ACCESS PODUCTS MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 102     REST OF THE WORLD HEMODIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
  • TABLE 103     REST OF THE WORLD PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
  • TABLE 104     REST OF THE WORLD PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 105     REST OF THE WORLD PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
  • TABLE 106     REST OF THE WORLD PERITONEAL DIALYSIS MARKET REVENUE, BY END-USERS (2014-2022) ($MN)
  • TABLE 107     REST OF THE WORLD IN- CENTRE DIALYSIS DEVICES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 108     REST OF THE WORLD HOME DIALYSIS DEVICES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
  • TABLE 109     AGREEMENTS & EXPANSIONS (2013-2016)
  • TABLE 110     MERGERS & ACQUISTIONS (2013-2016)
  • TABLE 111     APPROVALS (2013-2016)
  • TABLE 112     NEW PRODUCT LAUNCHES (2013-2016)
  • TABLE 113     ASAHI KASEI CORP. : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 114     ASAHI KASEI CORP. : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 115     ASAHI KASEI CORP. : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 116     B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 117     B.BRAUN MELSUNGEN AG: TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 118     B.BRAUN MELSUNGEN AG: TOTAL REVENUE BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 119     BAXTER INTERNATIONAL, INC : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 120     BAXTER INTERNATIONAL, INC : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 121     BAXTER INTERNATIONAL, INC : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 122     FRESENIUS SE & CO. KGAA : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 123     FRESENIUS SE & CO. KGAA : TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 124     FRESENIUS MEDICAL CARE : TOTAL REVENUE, BY PRODUCTS & SERVICES, (2013-2015) ($MN)
  • TABLE 125     FRESENIUS MEDICAL CARE : TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 126     JMS CO. LTD. : TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
  • TABLE 127     JMS CO. LTD. : TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 128     JMS CO. LTD.: TOTAL REVENUE BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 129     KAWASUMI LABORATORIES, INC. : TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
  • TABLE 130     KAWASUMI LABORATORIES, INC. : TOTAL REVENUE BY SEGMENTS (2013-2015) ($MN)
  • TABLE 131     KAWASUMI LABORATORIES, INC. : TOTAL REVENUE BY GEOGRAPHY (2013-2015) ($MN)
  • TABLE 132     NIKKISO CO., LTD : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 133     NIKKISO CO., LTD : TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 134     NIKKISO CO., LTD : TOTAL REVENUE BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 135     NIPRO CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 136     NIPRO CORPORATION : TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 137     NIPRO CORPORATION : TOTAL REVENUE BY GEOGRAPHY, (2013-2015) ($MN)
  • TABLE 138     NXSTAGE MEDICAL, INC. : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 139     NXSTAGE MEDICAL, INC. : TOTAL REVENUE, BY SEGMENTS, (2013-20145) ($MN)
  • TABLE 140     TORAY INDUSTRIES INC. : TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
  • TABLE 141     TORAY INDUSTRIES, INC. : TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN)
  • TABLE 142     TORAY INDUSTRIES INC. : TOTAL REVENUE BY GEOGRAPHY, (2013-2015) ($MN)
    •  

LIST OF FIGURES

    •  
    • FIGURE 1     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 2     DIALYSIS DEVICES GLOBAL MARKET: RESEARCH APPROACH
    • FIGURE 3     DIALYSIS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
    • FIGURE 4     DIALYSIS DEVICES GLOBAL MARKET: FORECASTING MODEL
    • FIGURE 5     DIALYSIS DEVICES GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
    • FIGURE 6     DIALYSIS DEVICES GLOBAL MARKET SEGMENTATION
    • FIGURE 7     MARKET DYNAMICS
    • FIGURE 8     DIALYSIS DEVICES MARKET: PORTER’S ANALYSIS
    • FIGURE 9     DIALYSIS DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
    • FIGURE 10     DIALYSIS DEVICES GLOBAL MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016)
    • FIGURE 11     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 12     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 13     HEMODIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
    • FIGURE 14     HEMODIALYSIS DEVICES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 15     HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 16     HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 17     CENTRE-USE HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 18     HOME-USE HEMODIALYSIS MACHINES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 19     HEMODIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 20     HEMODIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 21     HEMODIALYSIS GLOBAL MARKET REVENUE, BY MODALITIES, (2014-2022) ($MN)
    • FIGURE 22     PERITONIAL DIALYSIS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
    • FIGURE 23     PERITONIAL DIALYSIS GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
    • FIGURE 24     PERITONIAL DIALYSIS CONSUMABLES GLOBAL MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
    • FIGURE 25     PERITONIAL DIALYSIS GLOBAL MARKET REVENUE, BY MODALITY, (2014-2022) ($MN)
    • FIGURE 26     DIALYSIS END-USERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 27     IN-CENTER DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY SEGMENT, (2014-2022) ($MN)
    • FIGURE 28     HOME DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY SEGMENT, (2014-2022) ($MN)
    • FIGURE 29     DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
    • FIGURE 30     NORTH AMERICAN DIALYSIS DEVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 31     NORTH AMERICAN DIALYSIS DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
    • FIGURE 32     NORTH AMERICAN HEMODIALYSIS DEVICES CONSUMABLES MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
    • FIGURE 33     NORTH AMERICAN HEMODIALYSIS DEVICES MARKET REVENUE, BY MODALITIES, (2014-2022) ($MN)
    • FIGURE 34     NORTH AMERICAN PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN)
    • FIGURE 35     NORTH AMERICAN PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
    • FIGURE 36     NORTH AMERICAN PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES, (2014-2022) ($MN)
    • FIGURE 37     NORTH AMERICAN DIALYSIS DEVICES MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
    • FIGURE 38     EUROPEAN DIALYSIS DEVICES MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
    • FIGURE 39     EUROPEAN DIALYSIS DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
    • FIGURE 40     EUROPEAN HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS, (2014-2022) ($MN)
    • FIGURE 41     EUROPEAN HEMODIALYSIS DEVICES MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
    • FIGURE 42     EUROPEAN PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
    • FIGURE 43     EUROPEAN PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
    • FIGURE 44     EUROPEAN PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
    • FIGURE 45     EUROPEAN PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
    • FIGURE 46     ASIA-PACIFIC DIALYSIS DEVICES MARKET REVENUE, BY TYPE (2014-2022) ($MN)
    • FIGURE 47     ASIA-PACIFIC HEMODIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
    • FIGURE 48     ASIA-PACIFIC HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022)($MN)
    • FIGURE 49     ASIA-PACIFIC HEMODIALYSIS DEVICES MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
    • FIGURE 50     ASIA-PACIFIC PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
    • FIGURE 51     ASIA-PACIFIC PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
    • FIGURE 52     ASIA-PACIFIC PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
    • FIGURE 53     ASIA-PACIFIC PERITONEAL DIALYSIS MARKET REVENUE, BY END-USERS (2014-2022) ($MN)
    • FIGURE 54     REST OF THE WORLD DIALYSIS MARKET REVENUE, BY TYPES (2014-2022) ($MN)
    • FIGURE 55     REST OF THE WORLD HEMODIALYSIS DEVICES MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
    • FIGURE 56     REST OF THE WORLD HEMODIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
    • FIGURE 57     REST OF THE WORLD HEMODIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
    • FIGURE 58     REST OF THE WORLD PERITONEAL DIALYSIS MARKET REVENUE, BY PRODUCTS (2014-2022) ($MN)
    • FIGURE 59     REST OF THE WORLD PERITONEAL DIALYSIS CONSUMABLES MARKET REVENUE, BY SEGMENTS (2014-2022) ($MN)
    • FIGURE 60     REST OF THE WORLD PERITONEAL DIALYSIS MARKET REVENUE, BY MODALITIES (2014-2022) ($MN)
    • FIGURE 61     REST OF THE WORLD PERITONEAL DIALYSIS MARKET REVENUE, BY END-USERS (2014-2022) ($MN)
    • FIGURE 62     KEY GROWTH STRATEGIES, (2013 – 2016)
    • FIGURE 63     SWOT: ASAHI KASEI CORP.
    • FIGURE 64     SWOT: B.BRAUN MELSUNGEN AG
    • FIGURE 65     SWOT: BAXTER INTERNATIONAL, INC.
    • FIGURE 66     SWOT: FRESENIUS SE & CO. KGAA
    • FIGURE 67     SWOT: JMS CO. LTD.
    • FIGURE 68     SWOT: KAWASUMI LABORATORIES, INC.
    • FIGURE 69     SWOT: NIKKISO CO., LTD
    • FIGURE 70     SWOT: NIPRO CORPORATION
    • FIGURE 71     SWOT: NXSTAGE MEDICAL, INC.
    • FIGURE 72     SWOT: TORAY INDUSTRIES INC.

LIST OF COMPANIES MENTIONED IN THE REPORT

  • 1     ALLMED MEDICAL GMBH
  • 2     AMECATH
  • 3     ANGIODYNAMICS
  • 4     ARROW INTERNATIONAL INC.
  • 5     ASAHI KASEI
  • 6     B.BRAUN
  • 7     BALLYA INTERNATIONAL LIMITED
  • 8     BALTON SP. Z O.O.
  • 9     BAXTER INTERNATIONAL INC.
  • 10     BROWNDOVE HEALTHCARE (P) LTD
  • 11     CANTEL MEDICAL CORP.
  • 12     CARDIOMED SUPPLIES INC.
  • 13     CHENGDU WEILISHENG BIOTECH CO.,LTD
  • 14     COOK MEDICAL
  • 15     CR BARD
  • 16     DIALIFE SA
  • 17     ELCAM MEDICAL
  • 18     FARMASOL
  • 19     FRESENIUS SE & CO. KGAA
  • 20     GIFU PLASTIC INDUSTRY CO., LTD.
  • 21     GPC MEDICAL LTD.
  • 22     HIGH PURITY WATER SERVICES INC
  • 23     ISOPURE CORP.
  • 24     JIANGXI SANXIN MEDICAL DEVICES GROUP LTD
  • 25     JMS CO., LTD.
  • 26     KAWASUMI LABORATORIES
  • 27     KIMAL PLC.
  • 28     LIFELINE SERVICES PVT. LTD
  • 29     MEDICAL COMPONENTS, INC.
  • 30     MEDIONICS INTERNATIONAL INC.
  • 31     MEDTRONIC
  • 32     MERIT MEDICAL SYSTEMS, INC.
  • 33     MITRA INDUSTRIES
  • 34     NEPHROS, INC.
  • 35     NEWSOL TECHNOLOGIES INC.
  • 36     NIKKISO
  • 37     NINGBO TIANYI MEDICAL APPLIANCE CO.,LTD
  • 38     NIPRO
  • 39     NXSTAGE
  • 40     OHYON MEDICAL DEVICES CO., LTD.
  • 41     OUTSET MEDICAL
  • 42     PACIFIC HOSPITAL SUPPLY CO., LTD.
  • 43     RENACON PHARMA LTD.
  • 44     RENAX BIOMEDICAL TECH. CO, LTD
  • 45     SHANGHAI HENGXIN MEDICAL DEVICES CO., LTD.
  • 46     SUNDER BIOMEDICAL TECH. CO., LTD.
  • 47     SURNI GROUP
  • 48     SWS HEMODIALYSIS MEDICAL CARE. CO, LTD
  • 49     TORAY MEDICAL CO., LTD.
  • 50     UNIPHARM JSC.
  • 51     UTAH MEDICAL PRODUCTS INC.,
  • 52     W. L. GORE & ASSOCIATES, INC.
  • 53     WEIGAO GROUP